Clinical Trial Update: Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing paclitaxel and carboplatin with or without epirubicin in stage IIB-IV invasive ovarian epithelial, fallopian tube, or primary peritone…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Epirubicin (Ellence) (epirubicin)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: Nordic Society of Gynaecological Oncology - Clinical Trials Unit | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 3 | Status: COMPLETED